The effectiveness of three repurposed drugs to prevent severe SARS-CoV-2 infection in non-hospitalized adults
In a recent study published in NEJM, researchers conducted a phase III clinical trial to test the effectiveness of three repurposed drugs—metformin, ivermectin, and fluvoxamine—in preventing progression to severe coronavirus disease 2019 (COVID- 19). Study: Randomized trial of metformin, ivermectin and fluvoxamine for Covid-19. Image credit: Robert Coolen/Shutterstock background Current vaccines and inpatient treatments for …